Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Personalised cancer vaccine may hold leukaemia at bay for longer

A cancer vaccine personalised to individual patients could reduce the chances of a type of blood cancer from returning, a small US study has found.

Reprogrammed immune cells fight advanced leukaemia

A specialised therapy that uses a patient’s own genetically altered cells could be an effective treatment for advanced leukaemia.

Scientists solve arsenic's cancer paradox

Cancer Research UK scientists have discovered how arsenic works as an effective treatment for leukaemia.

Study links inherited genes, leukaemia drug toxicity

A study has revealed that variations in genes can affect the likelihood of children with leukaemia to having side-effects from chemotherapy.

Scientists to study possible link between pregnancy caffeine and childhood leukaemia

British scientists are to carry out a study into caffeine consumption during pregnancy and a possible increased risk of childhood leukaemia.

Scientists demonstrate potential new treatment for most common form of infant leukaemia

A team lead by Cancer Research UK scientists have shown that a potential new drug could treat mixed-lineage leukaemia (MLL), the most common form of leukaemia in babies,...

US researchers unveil womb cancer and acute leukaemia genomes

US researchers have published details of the genetic makeup of two more forms of cancer - acute myeloid leukaemia (AML) and womb (endometrial) cancer.

Cardiff scientists take on leukaemia with drugs personalised to individual patients

Cardiff scientists are treating leukaemia by trialling new drugs tailored to individual patientsї genetic make-up.

Potential new way to treat childhood leukaemia identified

An international team of scientists has discovered a potential new treatment target for T-cell acute lymphoblastic leukaemia (T-ALL).

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.